Subsequent studies demonstrated that SATB1-overexpressing CAR-T cells exhibited improved resistance to exhaustion and superior immunotherapeutic efficacy in vivo, leading to accelerated tumor eradication and prolonged survival of tumor-bearing mice. This evidence concerns the gene SATB1 and neoplasm.